版本:
中国

BRIEF-Fortress Biotech appoints Lung Yam as CEO of Cyprium

March 14 Fortress Biotech Inc-

* Fortress Biotech forms new subsidiary, Cyprium Therapeutics to develop novel therapies for menkes disease and related copper metabolism disorders

* Announced appointment of Lung S. Yam as chief executive officer of Cyprium Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐